Patents by Inventor Michael Soldan

Michael Soldan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220401476
    Abstract: The present invention provides compounds and compositions for use in the treatment of cancer as part of a Chimeric Antigen Receptor T-cell (CAR-T) therapy. In particular, the present invention discloses IL-18 binding molecules such as, for example, the IL-18 binding protein (IL-18BP) for use in Chimeric Antigen Receptor T-cell (CAR-T) therapy as a modulator to avoid or minimize side effects.
    Type: Application
    Filed: July 23, 2021
    Publication date: December 22, 2022
    Inventors: Eduardo SCHIFFRIN, Michael SOLDAN
  • Publication number: 20110229465
    Abstract: The present invention provides pharmaceutical compositions and kits comprising an agent capable of activating CD4+CD25+ regulatory T cells and methotrexate, and methods of treatment and medical uses utilising the same.
    Type: Application
    Filed: March 29, 2011
    Publication date: September 22, 2011
    Inventors: Frank Osterroth, Silke Aigner, Christoph Uherek, Andrea Wartenberg-Demand, Anatoly Rudnev, Michael Soldan, Christoph Bruecher, Benjamin Daelken, Chantal Zuber, Gregor Schulz, Niklas Czeloth